In the BioHarmony Drug Report Database
Profenal, Pedea (suprofen) is a small molecule pharmaceutical. Suprofen was first approved as Profenal on 1988-12-23. It has been approved in Europe to treat patent ductus arteriosus. The pharmaceutical is active against prostaglandin G/H synthase 1 and prostaglandin G/H synthase 2.
Image (chem structure or protein)